These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A once-yearly IV bisphosphonate for osteoporosis. Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523 [No Abstract] [Full Text] [Related]
23. [Treatment and prevention of osteoporosis in patients with decreased renal function]. Vestergaard P; Eiken PA Ugeskr Laeger; 2008 Jan; 170(4):227-30. PubMed ID: 18282452 [TBL] [Abstract][Full Text] [Related]
24. Annual zoledronic acid for osteoporosis. BMJ Group Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701 [TBL] [Abstract][Full Text] [Related]
25. Interventions to improve inpatient osteoporosis management following first osteoporotic fracture: the PREVENT project. Carpintero P; Gil-Garay E; Hernández-Vaquero D; Ferrer H; Munuera L Arch Orthop Trauma Surg; 2009 Feb; 129(2):245-50. PubMed ID: 19125257 [TBL] [Abstract][Full Text] [Related]
26. Bisphosphonates: a once-yearly treatment option with Reclast. Van Gilder D S D Med; 2008 Nov; 61(11):416-7. PubMed ID: 19066136 [No Abstract] [Full Text] [Related]
27. Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models. Zambon A; Baio G; Mazzaglia G; Merlino L; Corrao G Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):260-9. PubMed ID: 18240162 [TBL] [Abstract][Full Text] [Related]
29. The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy. Oberender P; Zerth J Eur J Health Econ; 2008 May; 9(2):127-36. PubMed ID: 17447094 [TBL] [Abstract][Full Text] [Related]
30. Oral bisphosphonates and osteonecrosis of the jaw. Wynn RL Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956 [No Abstract] [Full Text] [Related]
31. Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study. Rodrigues P; Hering FO; Bruna P; Meller A; Afonso Y Int J Urol; 2007 Apr; 14(4):317-20. PubMed ID: 17470161 [TBL] [Abstract][Full Text] [Related]
32. Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients. Chae YS; Kim JG; Moon JH; Kim SN; Lee SJ; Kim YJ; Sohn SK Bone Marrow Transplant; 2009 Jul; 44(1):35-41. PubMed ID: 19139732 [TBL] [Abstract][Full Text] [Related]
33. Weekly osteoporosis treatments also problematic. Health News; 2005 Apr; 11(4):15. PubMed ID: 15816094 [No Abstract] [Full Text] [Related]
34. [Counseling of osteoporosis patients. To take time for the patient]. Semler J MMW Fortschr Med; 2005 Aug; 147(31-32):45. PubMed ID: 16128199 [No Abstract] [Full Text] [Related]